Literature DB >> 23143057

The acute immunological response to blood transfusion is influenced by polymicrobial sepsis.

Dina C Nacionales1, Alex G Cuenca, Ricardo Ungaro, Lori F Gentile, Dallas Joiner, Minoru Satoh, Joanne Lomas-Neira, Alfred Ayala, Azra Bihorac, Matthew J Delano, Darwin N Ang, Philip A Efron.   

Abstract

Blood transfusion is a well-established risk factor for adverse outcomes during sepsis. The specific mechanisms responsible for this effect remain elusive, and few studies have investigated this phenomenon in a model that reflects not only the clinical circumstances in which blood is transfused, but also how packed red blood cells (PRBCs) are created and stored. Using a cecal ligation and puncture model of polymicrobial sepsis as well as creating murine allogeneic and stored PRBCs in a manner that replicates the clinical process, we have demonstrated that transfusion of PRBCs induces numerous effects on leukocyte subpopulations. In polymicrobial sepsis, these responses are profoundly dissimilar to the proinflammatory effects of PRBC transfusion observed in the healthy mouse. Transfused septic mice, as opposed to mice receiving crystalloid resuscitation, had a significant loss of blood, spleen, and bone marrow lymphocytes, especially those with an activated phenotype. Myeloid cells behaved similarly, although they were able to produce more reactive oxygen species. Overall, transfusion in the septic mouse may contribute to the persistent immune dysfunction known to be associated with this process, rather than simply promote proinflammatory or anti-inflammatory effects on the host. Thus, it is possible that blood transfusion contributes to the multiple known effects of sepsis on leukocyte populations that have been shown to result in increased morbidity and mortality.

Entities:  

Mesh:

Year:  2012        PMID: 23143057      PMCID: PMC3501604          DOI: 10.1097/SHK.0b013e318273621a

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  35 in total

1.  The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial.

Authors:  Avery B Nathens; Theresa A Nester; Gordon D Rubenfeld; Raminder Nirula; Terry B Gernsheimer
Journal:  Shock       Date:  2006-10       Impact factor: 3.454

2.  Blood transfusion--when is more really less?

Authors:  Howard L Corwin; Jeffrey L Carson
Journal:  N Engl J Med       Date:  2007-04-19       Impact factor: 91.245

Review 3.  Transfusion-related immunomodulation (TRIM): an update.

Authors:  Eleftherios C Vamvakas; Morris A Blajchman
Journal:  Blood Rev       Date:  2007-09-04       Impact factor: 8.250

4.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.

Authors:  P C Hébert; G Wells; M A Blajchman; J Marshall; C Martin; G Pagliarello; M Tweeddale; I Schweitzer; E Yetisir
Journal:  N Engl J Med       Date:  1999-02-11       Impact factor: 91.245

5.  Transfusion of fresh murine red blood cells reverses adverse effects of older stored red blood cells.

Authors:  Jeanne E Hendrickson; Eldad A Hod; Krystalyn E Hudson; Steven L Spitalnik; James C Zimring
Journal:  Transfusion       Date:  2011-06-03       Impact factor: 3.157

Review 6.  Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature.

Authors:  Paul E Marik; Howard L Corwin
Journal:  Crit Care Med       Date:  2008-09       Impact factor: 7.598

7.  Duration of red-cell storage and complications after cardiac surgery.

Authors:  Colleen Gorman Koch; Liang Li; Daniel I Sessler; Priscilla Figueroa; Gerald A Hoeltge; Tomislav Mihaljevic; Eugene H Blackstone
Journal:  N Engl J Med       Date:  2008-03-20       Impact factor: 91.245

8.  Stored red blood cell transfusion induces regulatory T cells.

Authors:  Joel M Baumgartner; Christopher C Silliman; Ernest E Moore; Anirban Banerjee; Martin D McCarter
Journal:  J Am Coll Surg       Date:  2008-10-10       Impact factor: 6.113

9.  Blood product transfusion and ventilator-associated pneumonia in trauma patients.

Authors:  Grant V Bochicchio; Lena Napolitano; Manjari Joshi; Kelly Bochicchio; Diane Shih; Walter Meyer; Thomas M Scalea
Journal:  Surg Infect (Larchmt)       Date:  2008-08       Impact factor: 2.150

10.  MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis.

Authors:  Matthew J Delano; Philip O Scumpia; Jason S Weinstein; Dominique Coco; Srinivas Nagaraj; Kindra M Kelly-Scumpia; Kerri A O'Malley; James L Wynn; Svetlana Antonenko; Samer Z Al-Quran; Ryan Swan; Chun-Shiang Chung; Mark A Atkinson; Reuben Ramphal; Dmitry I Gabrilovich; Wesley H Reeves; Alfred Ayala; Joseph Phillips; Drake Laface; Paul G Heyworth; Michael Clare-Salzler; Lyle L Moldawer
Journal:  J Exp Med       Date:  2007-06-04       Impact factor: 14.307

View more
  4 in total

Review 1.  The future of murine sepsis and trauma research models.

Authors:  Philip A Efron; Alicia M Mohr; Frederick A Moore; Lyle L Moldawer
Journal:  J Leukoc Biol       Date:  2015-06-01       Impact factor: 4.962

2.  Determination of RBC Survival in C57BL/6 and C57BL/6-Tg(UBC-GFP) Mice.

Authors:  Urshulaa Dholakia; Sheila Bandyopadhyay; Eldad A Hod; Kevin A Prestia
Journal:  Comp Med       Date:  2015-06       Impact factor: 0.982

3.  Red cell transfusions as an independent risk for mortality in critically ill children.

Authors:  Surender Rajasekaran; Eric Kort; Richard Hackbarth; Alan T Davis; Dominic Sanfilippo; Robert Fitzgerald; Sandra Zuiderveen; Akunne N Ndika; Hilary Beauchamp; Anthony Olivero; Nabil Hassan
Journal:  J Intensive Care       Date:  2016-01-07

4.  Clinical characteristics and risk factors of polymicrobial Staphylococcus aureus bloodstream infections.

Authors:  Cheng Zheng; Shufang Zhang; Qingqing Chen; Li Zhong; Tiancha Huang; Xijiang Zhang; Kai Zhang; Hongwei Zhou; Jiachang Cai; Linlin Du; Changming Wang; Wei Cui; Gensheng Zhang
Journal:  Antimicrob Resist Infect Control       Date:  2020-05-27       Impact factor: 4.887

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.